Updated: 07 Jan 2001
Colircusi benoxinato 0.4% colirio 10 ml
Anestesicos locales oftalmicos
La dosis usual es de 1-3 gotas. Usar bajo supervisión médica.
This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In the Knowledge Centre, you will find a disease overview, symposium highlights platform, video channel and additional resources including an events calendar and useful external links. This resource has been given a whole new look and feel, intended to improve accessibility and visual appeal. Recent content additions include a frequently asked questions section, case studies from urticaria experts Professor Christian Vestergaard and Professor Torsten Zuberbier and information on the TARGET My Hives app.
Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.
This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.
La seguridad y eficacia del uso de anestésicos locales oftálmicos en niños no han sido establecidas.
No se prevén problemas específicamente geriátricos en este grupo de edad.
Excepcionalmente, reacciones alérgicas. Temporalmente, quemazón, ardor y enrojecimiento conjuntival. Lesiones oculares a causa de falta de lubrificación (con uso incontrolado).
See disease awareness facts and stats, information on sebelipase alfa (the first and only licensed treatment for LAL-D) and resources section, including expert video channel…